Welcome! It's on Tuesday 18th June 2013

Pharmacy

  • EU gives Celgene go-ahead for Revlimid

    The European Commission has granted approval to Revlimid (lenalidomide) for the treatment of patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are failing.

  • Peter Dodds

    Peers debate patient choice

    The debate over a pharmacy law that forces patients away from GPs who dispense pharmaceuticals is heating up in the House of Lords with a series of questions from five peers to Earl Howe, England’s pharmacy minister.

  • Neal Patel

    Free prescriptions should be norm for LTCs

    People who have long-term conditions should all be able to get their prescription medicines free of charge, finds a report just published by the Prescription Charges Coalition.

  • Dr Val Harpin, Consultant Neurodevelopmental Paediatrician

    MHRA gives go-ahead for ADHD drug therapy

    Healthcare practitioners treating children who have attention deficit/hyperactivity disorder (ADHD) will soon have a new treatment option called Elvanse (lisdexamfetamine dimesylate) from Shire UK.

  • Vanilla Souvenaid

    Medical drink launched for Alzheimer’s patients

    Nutricia, a division of Danone, has just launched Souvenaid for people who are in the early stages of Alzheimer’s Disease. Souvenaid is a ‘Food for Special Medical Purposes’ that is loaded with the nutrients needed to maintain healthy synapses.

  • Single drug may ease chronic back pain

    Patients who have chronic lower back pain are typically prescribed more than one drug to manage their pain, with one in five patients taking at least four types of drugs a day.

  • National Institute for Health and Clinical Excellence

    NICE recommends new drug to treat blood clots

    In final guidance published today (25 July), NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for treating deep vein thrombosis and preventing recurrent deep vein thrombosis and pulmonary embolism in adults diagnosed with acute deep vein thrombosis (DVT).